Document is current
Any future updates will be listed below
-
Authors
Grant, Jane https://orcid.org/0000-0002-1607-4042
Sagara, Issaka
Zongo, Issaka
Cairns, Matthew
Yerbanga, Rakiswendé Serge
Diarra, Modibo
Zoungrana, Charles
Issiaka, Djibrilla
Nikièma, Frédéric
Sompougdou, Frédéric
Tapily, Amadou
Kaya, Mahamadou
Haro, Alassane
Sanogo, Koualy
Sienou, Abdoul Aziz
Traore, Seydou
Thera, Ismaila
Yalcouye, Hama
Kuepfer, Irene
Snell, Paul
Milligan, Paul
Ockenhouse, Christian
Ofori-Anyinam, Opokua
Tinto, Halidou
Djimde, Abdoulaye
Chandramohan, Daniel
Greenwood, Brian
Dicko, Alassane
Ouédraogo, Jean-Bosco
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03143218 at ClinicalTrials.govDocuments that mention this clinical trial
Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali
https://doi.org/10.1186/s12936-022-04077-x
Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01<sub>E</sub>vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention (Pre-results)
https://doi.org/10.1136/bmjopen-2019-035433
-
Funding
Funding for this research was provided by:
United Kingdom Joint Global Health Trials (MR/P006876/1)
PATH (18269)
- License Information
-
More Information
Article History
Received: 8 November 2021
Accepted: 6 February 2022
First Online: 22 February 2022
Declarations
:
: The trial was approved by the ethics committees of the London School of Hygiene and Tropical Medicine; the Ministry of Health of Burkina Faso; the University of Sciences, Techniques, and Technologies of Bamako; and the national regulatory authorities of Burkina Faso and Mali. The trial adheres to the principles outlined in the International Conference on Harmonisation Good Clinical Practice (ICH GCP) guidelines, protocol and all applicable local regulations. The trial is registered on clinicaltrials.gov (). Written informed consent was obtained from the parents or guardians of all study participants.
: Not applicable.
: OOA is an employee of the GSK group of companies and reports ownership of shares and/or restricted shares of the GSK group of companies. None of the other authors declare any competing interests.
